BR9708518A - Moduladores de fator associado a receptor tnf (traf) sua preparação e uso - Google Patents
Moduladores de fator associado a receptor tnf (traf) sua preparação e usoInfo
- Publication number
- BR9708518A BR9708518A BR9708518A BR9708518A BR9708518A BR 9708518 A BR9708518 A BR 9708518A BR 9708518 A BR9708518 A BR 9708518A BR 9708518 A BR9708518 A BR 9708518A BR 9708518 A BR9708518 A BR 9708518A
- Authority
- BR
- Brazil
- Prior art keywords
- traf
- modulators
- preparation
- tnf receptor
- factor associated
- Prior art date
Links
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 title 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11780096A IL117800A0 (en) | 1996-04-02 | 1996-04-02 | Modulators of TNF receptor associated factor (TRAF) their preparation and use |
| IL11913396A IL119133A0 (en) | 1996-08-26 | 1996-08-26 | Modulators of TNF receptor associated factor (TRAF) their preparation and use |
| PCT/IL1997/000117 WO1997037016A1 (en) | 1996-04-02 | 1997-04-01 | Modulators of tnf receptor associated factor (traf), their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9708518A true BR9708518A (pt) | 1999-08-03 |
Family
ID=26323248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9708518A BR9708518A (pt) | 1996-04-02 | 1997-04-01 | Moduladores de fator associado a receptor tnf (traf) sua preparação e uso |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7485456B1 (pt) |
| EP (1) | EP0894130B1 (pt) |
| JP (1) | JP4180114B2 (pt) |
| CN (1) | CN1197966C (pt) |
| AT (1) | ATE380866T1 (pt) |
| AU (1) | AU732793B2 (pt) |
| BG (1) | BG64755B1 (pt) |
| BR (1) | BR9708518A (pt) |
| CA (1) | CA2250085C (pt) |
| CZ (3) | CZ299682B6 (pt) |
| DE (1) | DE69738370T2 (pt) |
| DK (1) | DK0894130T3 (pt) |
| EA (1) | EA004309B1 (pt) |
| EE (1) | EE04783B1 (pt) |
| ES (1) | ES2294796T3 (pt) |
| HU (1) | HU226328B1 (pt) |
| NO (1) | NO327054B1 (pt) |
| NZ (1) | NZ331902A (pt) |
| PT (1) | PT894130E (pt) |
| SK (3) | SK287085B6 (pt) |
| UA (1) | UA71889C2 (pt) |
| WO (1) | WO1997037016A1 (pt) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA71889C2 (uk) * | 1996-04-02 | 2005-01-17 | Йєда Рісерч Енд Дівелопмент Ко. Лтд. | Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування |
| US5843721A (en) * | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
| JP2003525567A (ja) * | 1997-11-07 | 2003-09-02 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | 分泌蛋白およびそれらをコードするポリヌクレオチド |
| US6265538B1 (en) * | 1998-02-27 | 2001-07-24 | The Regents Of The University Of California | Inhibitor of the inflammatory response induced by the TNFA and IL-1 |
| DE69928244T2 (de) * | 1998-05-06 | 2006-08-10 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | Inhibitoren der nf-kb aktivierung |
| TR200100624T2 (tr) * | 1998-08-18 | 2001-08-21 | Aktiengesellschaft Basf | TPL-2/Cot kinaz ve kullanım yöntemleri. |
| IL131719A0 (en) * | 1999-09-02 | 2001-03-19 | Yeda Res & Dev | Iren protein its preparation and use |
| GB9930616D0 (en) * | 1999-12-24 | 2000-02-16 | Mathilda & Terence Kennedy Ins | Activation and inhibition of the immune system |
| US20040109854A1 (en) * | 2001-02-21 | 2004-06-10 | Zang-Hee Lee | Novel traf6 inhibiting protein |
| AU2002350412B2 (en) | 2001-06-22 | 2006-06-15 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Abin-mediated hepatitis protection |
| EP1499729B9 (en) * | 2002-04-18 | 2012-03-14 | Yeda Research And Development Co., Ltd. | Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| IL158287A0 (en) * | 2003-10-07 | 2004-05-12 | Yeda Res & Dev | Antibodies to nik, their preparation and use |
| WO2005033145A1 (en) * | 2003-10-07 | 2005-04-14 | Yeda Research And Development Co. Ltd. | Antibodies to nik, their preparation and use |
| CA2547459C (en) * | 2003-11-30 | 2013-10-08 | Yeda Research And Development Co. Ltd | Modulators of nik-siva complex formation for treating immune disorders |
| IL173104A0 (en) * | 2006-01-12 | 2006-06-11 | Yeda Res & Dev | Siva and ubiquintination |
| ES2752025T3 (es) | 2008-07-25 | 2020-04-02 | Wagner Richard W | Métodos de cribado de proteínas |
| GB201012420D0 (en) | 2010-07-23 | 2010-09-08 | Univ Erasmus Medical Ct | Foetal heamoglobin inhibitor |
| CA2808539C (en) | 2010-08-25 | 2021-05-25 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases |
| CN105177032B (zh) * | 2010-09-01 | 2019-05-10 | 山东新时代药业有限公司 | 新型人肿瘤坏死因子受体-Fc融合基因及其产物蛋白 |
| WO2012123522A1 (en) | 2011-03-16 | 2012-09-20 | F. Hoffmann-La Roche Ag | 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| ES2810424T3 (es) | 2011-06-30 | 2021-03-08 | Genzyme Corp | Inhibidores de la activación de células T |
| EP2734232B1 (en) | 2011-07-19 | 2017-11-01 | Philogen S.p.A. | Sequential anti-ctla4 and targeted il-2 therapy |
| UY34317A (es) | 2011-09-12 | 2013-02-28 | Genzyme Corp | Anticuerpo antireceptor de célula T (alfa)/ß |
| CA2974651A1 (en) | 2014-01-24 | 2015-07-30 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Smc combination therapy for the treatment of cancer |
| CN105986001B (zh) * | 2015-02-12 | 2019-12-03 | 上海交通大学 | 一种基于膜结合蛋白和荧光互补的高通量猎物拮抗剂筛选方法 |
| EP3313887A2 (en) | 2015-06-26 | 2018-05-02 | MAB Discovery GmbH | Monoclonal anti-il-1racp antibodies |
| WO2020206063A1 (en) | 2019-04-03 | 2020-10-08 | Genzyme Corporation | Anti-alpha beta tcr binding polypeptides with reduced fragmentation |
| TW202428613A (zh) | 2022-09-21 | 2024-07-16 | 法商賽諾菲生物技術公司 | 人源化抗il-1r3抗體及使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5641876A (en) * | 1990-01-05 | 1997-06-24 | Cornell Research Foundation, Inc. | Rice actin gene and promoter |
| EP0841934A1 (en) * | 1995-08-02 | 1998-05-20 | Teresa J. Ingram | Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome |
| AU6692996A (en) * | 1995-08-08 | 1997-03-05 | Tularik Inc. | Inhibitors of apoptosis |
| US5804412A (en) * | 1996-04-01 | 1998-09-08 | The Regents Of The University Of California | Nucleic acids encoding sorting nexins and methods of using same |
| UA71889C2 (uk) * | 1996-04-02 | 2005-01-17 | Йєда Рісерч Енд Дівелопмент Ко. Лтд. | Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування |
| EP0904346A4 (en) | 1996-05-08 | 2000-11-29 | Henkel Corp | ALKYL POLYGLYCOSIDE ETHER CARBOXYLATES |
| US5843721A (en) * | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
-
1997
- 1997-01-04 UA UA98105743A patent/UA71889C2/uk unknown
- 1997-04-01 AU AU21755/97A patent/AU732793B2/en not_active Expired
- 1997-04-01 SK SK1361-98A patent/SK287085B6/sk not_active IP Right Cessation
- 1997-04-01 US US09/155,676 patent/US7485456B1/en not_active Expired - Fee Related
- 1997-04-01 WO PCT/IL1997/000117 patent/WO1997037016A1/en not_active Ceased
- 1997-04-01 PT PT97914534T patent/PT894130E/pt unknown
- 1997-04-01 CZ CZ0318398A patent/CZ299682B6/cs not_active IP Right Cessation
- 1997-04-01 DK DK97914534T patent/DK0894130T3/da active
- 1997-04-01 HU HU9902429A patent/HU226328B1/hu unknown
- 1997-04-01 SK SK50017-2007A patent/SK287890B6/sk not_active IP Right Cessation
- 1997-04-01 JP JP53509997A patent/JP4180114B2/ja not_active Expired - Lifetime
- 1997-04-01 EE EE9800322A patent/EE04783B1/xx unknown
- 1997-04-01 EA EA199800885A patent/EA004309B1/ru not_active IP Right Cessation
- 1997-04-01 SK SK50016-2007A patent/SK287889B6/sk not_active IP Right Cessation
- 1997-04-01 CA CA002250085A patent/CA2250085C/en not_active Expired - Lifetime
- 1997-04-01 BR BR9708518A patent/BR9708518A/pt not_active Application Discontinuation
- 1997-04-01 AT AT97914534T patent/ATE380866T1/de active
- 1997-04-01 CZ CZ20060017A patent/CZ298866B6/cs not_active IP Right Cessation
- 1997-04-01 EP EP97914534A patent/EP0894130B1/en not_active Expired - Lifetime
- 1997-04-01 CZ CZ20060018A patent/CZ299094B6/cs not_active IP Right Cessation
- 1997-04-01 CN CNB971951934A patent/CN1197966C/zh not_active Expired - Lifetime
- 1997-04-01 ES ES97914534T patent/ES2294796T3/es not_active Expired - Lifetime
- 1997-04-01 DE DE69738370T patent/DE69738370T2/de not_active Expired - Lifetime
- 1997-04-01 NZ NZ331902A patent/NZ331902A/en not_active IP Right Cessation
-
1998
- 1998-09-29 NO NO19984551A patent/NO327054B1/no not_active IP Right Cessation
- 1998-10-07 BG BG102817A patent/BG64755B1/bg unknown
-
2009
- 2009-02-03 US US12/365,136 patent/US8236507B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9708518A (pt) | Moduladores de fator associado a receptor tnf (traf) sua preparação e uso | |
| DE69022559D1 (de) | Expression des rekombinanten Tumor-Nekrosisfaktor-Bindungsproteins I (TBP-I). | |
| DK1012274T4 (da) | Dødsdomæneholdig receptor-4 (DR4: dødsreceptor 4), medlem af TNF-receptorsuperfamilien og som binder til TRAIL (Apo-2L) | |
| CY1108175T1 (el) | ΠΟΛΥΠΕΠΤΙΔΙΟ DcR3, ΟΜΟΛΟΓΟ TNFR | |
| WO1998041629A3 (en) | Death domain containing receptor 5 | |
| IL193886A0 (en) | Antibodies that bind to ldcam sequences | |
| WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
| DE69834852D1 (de) | NL3 TIE Rezeptortyrosinekinase Ligandhomologe | |
| NO961115L (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
| PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
| NO960767D0 (no) | Protocadherinproteiner og deres anvendelse | |
| FI964509A7 (fi) | TNF/NGF-superperhereseptoreiden muuntajia ja liukoisia, oligomeerisiä superperhereseptoreita | |
| WO2002036769A3 (en) | Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof | |
| TW200716746A (en) | Methods for identifying a compound modulating the binding between polypeptides | |
| WO2000066156A8 (en) | Death domain containing receptor 5 | |
| NZ315514A (en) | Tumour necrosis factor associated factor (traf) inhibitors including traf polypeptide, murine nucleotide sequence and associated assays | |
| FI863626A7 (fi) | DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä. | |
| WO2000024771A3 (en) | Nucleic acids encoding osteoprotegerin-like proteins and methods of using same | |
| EP0643728A4 (en) | PROTEIN RELATED TO INTERCELLULAR ADHESION MOLECULES. | |
| AU5166200A (en) | Human tumor necrosis factor receptor tr10 | |
| ATE408687T1 (de) | Semaphorin polypeptide | |
| MX9605531A (es) | Modulador de receptores de la superfamilia de factor de necrosis tumoral/factor de crecimiento de nervio y receptores oligomericos solubles de la superfamilia de factor de necrosis tumoral/factor de crecimiento necrotico. | |
| AR008064A1 (es) | Una proteina ligante del factor de necrosis tumoral truncada de bajo peso molecular (tnf bp), un polinucleotido codificante de dicha proteina, un vector, una celula hospedante, metodos para producir dicha proteina, una composicion farmaceutica, metodo para tratar una enfermedad mediada por tnf bp y usos de dicha proteina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 37, SUGIRO O INDEFERIMENTO DO PRESENTE PEDIDO, TENDO POR BASE OS ARTIGOS 10, 24, 25 DA LEI 9.279 DE 14/05/1996. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |